Exelixis Inc (EXEL)
21.76
+0.17
(+0.79%)
USD |
NASDAQ |
May 09, 16:00
21.75
-0.01
(-0.05%)
Pre-Market: 20:00
Exelixis Market Cap: 6.339B for May 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 6.339B |
| May 08, 2024 | 6.289B |
| May 07, 2024 | 6.452B |
| May 06, 2024 | 6.379B |
| May 03, 2024 | 6.379B |
| May 02, 2024 | 6.443B |
| May 01, 2024 | 6.387B |
| April 30, 2024 | 6.834B |
| April 29, 2024 | 6.912B |
| April 26, 2024 | 6.904B |
| April 25, 2024 | 6.854B |
| April 24, 2024 | 6.907B |
| April 23, 2024 | 6.784B |
| April 22, 2024 | 6.662B |
| April 19, 2024 | 6.639B |
| April 18, 2024 | 6.630B |
| April 17, 2024 | 6.742B |
| April 16, 2024 | 6.727B |
| April 15, 2024 | 6.692B |
| April 12, 2024 | 6.724B |
| April 11, 2024 | 6.677B |
| April 10, 2024 | 6.981B |
| April 09, 2024 | 6.993B |
| April 08, 2024 | 6.884B |
| April 05, 2024 | 6.822B |
| Date | Value |
|---|---|
| April 04, 2024 | 6.925B |
| April 03, 2024 | 6.984B |
| April 02, 2024 | 6.881B |
| April 01, 2024 | 6.981B |
| March 28, 2024 | 7.113B |
| March 27, 2024 | 7.152B |
| March 26, 2024 | 7.077B |
| March 25, 2024 | 7.104B |
| March 22, 2024 | 7.128B |
| March 21, 2024 | 7.170B |
| March 20, 2024 | 7.107B |
| March 19, 2024 | 7.035B |
| March 18, 2024 | 6.945B |
| March 15, 2024 | 6.888B |
| March 14, 2024 | 6.777B |
| March 13, 2024 | 6.915B |
| March 12, 2024 | 6.801B |
| March 11, 2024 | 6.732B |
| March 08, 2024 | 6.657B |
| March 07, 2024 | 6.621B |
| March 06, 2024 | 6.708B |
| March 05, 2024 | 6.672B |
| March 04, 2024 | 6.759B |
| March 01, 2024 | 6.666B |
| February 29, 2024 | 6.565B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.417B
Minimum
Mar 16 2020
8.409B
Maximum
May 11 2020
6.332B
Average
6.331B
Median
Jul 11 2019
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 106.66B |
| Johnson & Johnson | 360.64B |
| Merck & Co Inc | 329.85B |
| Pfizer Inc | 159.68B |
| Legend Biotech Corp | 8.281B |
Market Cap Related Metrics
| PE Ratio | 33.83 |
| PS Ratio | 3.727 |
| PEG Ratio | 0.9946 |
| Price to Book Value | 2.979 |
| Price to Free Cash Flow | 37.18 |
| Price | 21.76 |
| Earnings Yield | 2.96% |
| PEGY Ratio | 0.9946 |
| Operating PE Ratio | 33.68 |
| Normalized PE Ratio | 30.03 |